machine-readable data with high-impact applications across multiple industries." 1H 2025: VELDONA®, a low-dose oral interferon, received clearance in Taiwan to begin clinical trials for HIV-related ...

"The first half of 2025 was an inflection point for Ainos," said Eddy Tsai, Chairman, President & CEO. "Q1 revenue increased 412% year-over-year, primarily driven by our AI Nose project in Japan's ...

More data leads to more precise answers, and the biopharma industry has at its disposal more data than ever before.

The House of Representatives’ advancement of H.R.1, the “ One Big Beautiful Bill Act,” marks a significant step toward restoring longer-term certainty for farmers and ranchers after a series of ...

Intellia reports a big reduction in hereditary angioedema attacks in patients treated with its one-shot CRISPR drug, but its shares fall sharply.

Explore Karachi 100 historical data, featuring daily prices, open, high, low, volume, and changes. Analyze trends, all-time highs, historical returns, and more.

At the top end, 23andMe has said it would pay out up to $10,000 with an "Extraordinary Claim" to each customer who can verify that they suffered hardships as a direct result of their information ...

Match vs. R-Truth: Won (Saturday Night’s Main Event, May 24) This article originally appeared on USA TODAY: WWE Money in the Bank 2025 results, analysis: R-Truth returns, Seth Rollins and Naomi win ...